Janice Kuhn

7PUBLICATIONS
7CO-AUTHORS
Epidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyTissue engineeringExperimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2021
Real-world cost estimates of initiating emicizumab in US patients with haemophilia A.

Benjamin J Samelson-Jones, Christine Guelcher, Jan Kuhn

|Apr 29, 2021
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiency.

Erika J Martin, Melinda E Nolte, Janice Kuhn

|Apr 21, 2020
Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.

Isabella McCary, Christine Guelcher, Jan Kuhn

|Jul 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas.

Sunita Patel-Hett, Erika J Martin, Bassem M Mohammed

|Aug 17, 2018
Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activation.

Donald F Brophy, Erika J Martin, Marisa Ninivaggi

Pageof 2

Frequent Collaborators

4 joint publications

Donald F Brophy

2 joint publications

Christine Guelcher

2 joint publications

Leslie Raffini

1 joint publications

Benjamin J Samelson-Jones